Table 1. miRNA expression and its possible role in GC.
| miRNAs related to vitamin D | Potential role in GC | Expression in GC | Therapeutic potential in GC | Reference |
|---|---|---|---|---|
| miR-125 | Oncogene | Upregulated | Possible role in CDDP sensitivity and Trastuzumab resistance in GC cells | (80-83) |
| TS | Downregulated | |||
| miR-145 | TS | Downregulated | Possible role improving chemosensitivity to CDDP and 5FU in GC cells | (84,85) |
| miR-99 | Oncogene | Upregulated | Associated with CDDP resistance in GC cells | (86,87) |
| TS | Downregulated | |||
| miR-498 | TS | Downregulated | Possible role in overcoming CDDP resistance in GC cells | (88,89) |
| miR-22 | TS | Downregulated | Possible role in CDDP resistance in GC cells | (90-92) |
| miR-181 | Oncogene | Upregulated | – | (93-95) |
| TS | Downregulated | |||
| miR-106 | Oncogene | Upregulated | – | (96,97) |
| miR-532 | Oncogene | Upregulated | – | (98,99) |
| TS | Downregulated |
GC, gastric cancer; miR, microRNA; TS, tumor suppressor; CDDP, cisplatin; 5FU, 5-fluorouracil.